Management of metabolic syndrome and cardiovascular risk after liver transplantation
Open accessAbstract
Cardiovascular events are the second most prevalent cause of non-hepatic mortality in liver transplant recipients. The incidence of these events is projected to rise because of the growing prevalence of non-alcoholic steatohepatitis as a transplant indication and the ageing population of liver transplant recipients. Recipients with metabolic syndrome are up to four times more likely to have a cardiovascular event than recipients without, therefore prevention and optimal treatment of the components of metabolic syndrome are key in reducing the risk of these events. Although data on the treatment of metabolic comorbidities specifically in liver transplant recipients are scarce, there is detailed guidance from learned societies that mostly mirrors the guidance for patients at increased cardiovascular risk in the general population. In this Review, we discuss the management of the components of metabolic syndrome following liver transplantation and provide practical stepwise guidance. We also emphasise the need for adequately powered studies for the treatment of metabolic comorbidities in liver transplant recipients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cardiovascular complications are the second most common cause of non-hepatic mortality in liver transplant recipients.
“Cardiovascular complications are the second most common cause of non-hepatic mortality in liver transplant recipients, 512 and those with T2D 513 and chronic kidney disease 514 are at the highest risk for cardiovascular events.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [512]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325 · see citing works
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836 · see citing works
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082 · see citing works
O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. H. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31773-2 · Cited by 814 · see citing works
Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., & Charlton, M. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03126.x · Cited by 784 · see citing works
Goldberg, D. S., Ditah, I. C., Saeian, K., Lalehzari, M., Aronsohn, A. I., Gorospe, E. C., & Charlton, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.003 · Cited by 601 · see citing works
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544 · see citing works
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532 · see citing works
Nair, S. P., Verma, S., & Thuluvath, P. J. (2002) · Hepatology · doi:10.1053/jhep.2002.30318 · Cited by 419 · see citing works
Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, A. S., Fisher, R. A., Ham, J. M., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400 · see citing works
OPTN/SRTR 2016 Annual Data Report: Liver
Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., & Kasiske, B. L. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14559 · Cited by 400 · see citing works
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328 · see citing works
Cardiovascular morbidity and mortality after orthotopic liver transplantation
Johnston, S. D., Morris, J. K., Cramb, R., Gunson, B. K., & Neuberger, J. (2002) · Transplantation · doi:10.1097/00007890-200203270-00012 · Cited by 321 · see citing works
Laryea, M. A., Watt, K. D. S., Molinari, M., Walsh, M. J., McAlister, V. C., Marotta, P. J., Nashan, B., & Peltekian, K. M. (2007) · Liver Transplantation · doi:10.1002/lt.21126 · Cited by 316 · see citing works
Haldar, D., Kern, B., Hodson, J., Armstrong, M. J., Adam, R., Berlakovich, G., Fritz, J., Feurstein, B., Popp, W., Karam, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.011 · Cited by 313 · see citing works
Charlton, M., Levitsky, J., Aqel, B. A., O’Grady, J., Hemibach, J., Rinella, M. E., Fung, J. J., Ghabril, M., Thomason, R., Burra, P., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002147 · Cited by 311 · see citing works
Stone, N. J., Bilek, S., & Rosenbaum, S. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.006 · Cited by 270 · see citing works
Increased perioperative mortality following bariatric surgery among patients with cirrhosis
Mosko, J. D., & Nguyen, G. C. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.07.007 · Cited by 266 · see citing works
LONG-TERM MEDICAL COMPLICATIONS IN PATIENTS SURVIVING ???5 YEARS AFTER LIVER TRANSPLANT
Sheiner, P. A., Magliocca, J. F., Bodian, C., Kim‐Schluger, L., Altaca, G., Guarrera, J. V., Emre, S., Fishbein, T., Guy, S. R., Schwartz, M., et al. (2000) · Transplantation · doi:10.1097/00007890-200003150-00018 · Cited by 262 · see citing works
Metabolic syndrome and liver transplantation: A review and guide to management
Watt, K. D. S., & Charlton, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.040 · Cited by 243 · see citing works
Yalamanchili, K., Saadeh, S. N., Klintmalm, G. B. G., Jennings, L. W., & Davis, G. L. (2009) · Liver Transplantation · doi:10.1002/lt.22004 · Cited by 226 · see citing works
Leonard, J., Heimbach, J. K., Malinchoc, M., Watt, K. D. S., & Charlton, M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02100.x · Cited by 225 · see citing works
VanWagner, L. B., Bhave, M., Te, H. S., Feinglass, J., Alvarez, L., & Rinella, M. E. (2012) · Hepatology · doi:10.1002/hep.25855 · Cited by 220 · see citing works
Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil”
Dumortier, J., Giostra, E., Belbouab, S., Morard, I., Guillaud, O., Spahr, L., Boillot, O., Rubbia‐Brandt, L., Scoazec, J., & Hadengue, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.717 · Cited by 215 · see citing works
Cumulative Risk of Cardiovascular Events After Orthotopic Liver Transplantation
Albeldawi, M. J., Aggarwal, A., Madhwal, S., Cywiński, J. B., López, R., Eghtesad, B., & Zein, N. N. (2011) · Liver Transplantation · doi:10.1002/lt.22468 · Cited by 197 · see citing works
Moon, J., Barbeito, R., Faradji, R. N., Gaynor, J. J., & Tzakis, A. G. (2006) · Transplantation · doi:10.1097/01.tp.0000250361.60415.96 · Cited by 187 · see citing works
Rodríguez‐Perálvarez, M., Germani, G., Darius, T., Lerut, J., Tsochatzis, E. A., & Burroughs, A. K. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04140.x · Cited by 186 · see citing works
Self-citationStegall, M. D., Everson, G. T., Schröter, G., Bilir, B. M., Karrer, F. M., & Kam, I. (1995) · PubMed · Cited by 177 · see citing works
De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation
Seo, S., Maganti, K., Khehra, M., Ramsamooj, R., Tsodikov, A. D., Bowlus, C. L., McVicar, J. P., Zern, M. Α., & Torok, N. J. (2006) · Liver Transplantation · doi:10.1002/lt.20932 · Cited by 172 · see citing works
Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy
Zamora‐Valdes, D., Watt, K. D., Kellogg, T. A., Poterucha, J. J., Di Cecco, S. R., Francisco‐Ziller, N. M., Taner, T., Rosen, C. B., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29848 · Cited by 172 · see citing works
A Randomized Trial of Exercise and Dietary Counseling After Liver Transplantation
Krasnoff, J. B., Vintro, A. Q., Ascher, N. L., Bass, N. M., Paul, S. M., Dodd, M. J., & Painter, P. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01391.x · Cited by 167 · see citing works
Park, C., Hsu, C.-H., Neelakanta, G., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e31819cc3e6 · Cited by 146 · see citing works
Vallin, M., Guillaud, O., Boillot, O., Hervieu, V., Scoazec, J.-Y., & Dumortier, J. (2014) · Liver Transplantation · doi:10.1002/lt.23936 · Cited by 137 · see citing works
Outcome of liver transplantation in patients with diabetes mellitus: A case-control study
John, P. R., & Thuluvath, P. J. (2001) · Hepatology · doi:10.1053/jhep.2001.29134 · Cited by 136 · see citing works
Role of Prescription Omega‐3 Fatty Acids in the Treatment of Hypertriglyceridemia
McKenney, J. M., & Sica, D. A. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.5.715 · Cited by 131 · see citing works
Madhwal, S., Atreja, A., Albeldawdi, M., López, R., Post, A. B., & Costa, M. (2012) · Liver Transplantation · doi:10.1002/lt.23508 · Cited by 131 · see citing works
Effect of Intraoperative Hyperglycemia During Liver Transplantation
Ammori, J. B., Sigakis, M. J. G., Englesbe, M. J., O’Reilly, M., & Pelletier, S. J. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.02.019 · Cited by 130 · see citing works
Non-alcoholic fatty liver disease and the interface between primary and secondary care
Tsochatzis, E. A., & Newsome, P. N. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30077-3 · Cited by 130 · see citing works
Self-citationLong-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity
Reuben, A. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.29167 · Cited by 128 · see citing works
VanWagner, L. B., Ning, H., Whitsett, M. P., Levitsky, J., Uttal, S. E., Wilkins, J. T., Abecassis, M. M., Ladner, D. P., Skaro, A. I., & Lloyd‐Jones, D. M. (2017) · Hepatology · doi:10.1002/hep.29329 · Cited by 127 · see citing works
Rodríguez‐Perálvarez, M., Germani, G., Papastergiou, V., Tsochatzis, E. A., Thalassinos, E., Luong, T. V., Rolando, N., Dhillon, A. P., Patch, D., O’Beirne, J. P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.019 · Cited by 125 · see citing works
Self-citationThe Impact of Diabetes Mellitus on Fibrosis Progression in Patients Transplanted for Hepatitis C
Foxton, M., Quaglia, A., Muiesan, P., Heneghan, M. A., Portmann, B. C., Norris, S., Heaton, N. D., & O’Grady, J. G. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01408.x · Cited by 121 · see citing works
Post-transplant dyslipidemia: Mechanisms, diagnosis and management.
Agarwal, A., & Prasad, G. R. R. (2016) · World journal of transplantation · doi:10.5500/wjt.v6.i1.125 · Cited by 116 · see citing works
Nicolau‐Raducu, R., Gitman, M., Ganier, D., Loss, G. E., Cohen, A. J., Patel, H. M., Girgrah, N., Sekar, K., & Nossaman, B. D. (2014) · Liver Transplantation · doi:10.1002/lt.23997 · Cited by 114 · see citing works
Lazzati, A., Iannelli, A., Schneck, A.-S., Charles‐Nelson, A., Katsahian, S., Gugenheim, J., & Azoulay, D. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1430-8 · Cited by 113 · see citing works
Late mortality after orthotopic liver transplantation
Rabkin, J. M., Melena, V. D. L., Orloff, S. L., Corless, C. L., Rosen, H. R., & Olyaei, A. J. (2001) · The American Journal of Surgery · doi:10.1016/s0002-9610(01)00595-5 · Cited by 112 · see citing works
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation
Konerman, M. A., Fritze, D. M., Weinberg, R. L., Sonnenday, C. J., & Sharma, P. (2017) · Transplantation · doi:10.1097/tp.0000000000001710 · Cited by 108 · see citing works
Tsochatzis, E., Coilly, A., Nadalin, S., Levistky, J., Tokat, Y., Ghobrial, M., Klinck, J., & Berenguer, M. (2019) · Transplantation · doi:10.1097/tp.0000000000002433 · Cited by 105 · see citing works
Self-citationIs there disparity between risk and incidence of cardiovascular disease after liver transplant?
Neal, D. A. J., Tom, B. D. M., Luan, J., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000100685.70064.90 · Cited by 104 · see citing works
The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom
Gelson, W., Hoare, M., Dawwas, M. F., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31821841ba · Cited by 103 · see citing works
Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation
Narayanan, P., Mara, K. C., Izzy, M. J., Dierkhising, R., Heimbach, J. K., Allen, A. M., & Watt, K. D. S. (2018) · Transplantation · doi:10.1097/tp.0000000000002317 · Cited by 98 · see citing works
Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506)
Canzanello, V. J., Textor, S. C., Taler, S. J., Schwartz, L. L., Porayko, M. K., Wiesner, R. H., & Krom, R. A. F. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040404 · Cited by 95 · see citing works
Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
Germani, G., Laryea, M. A., Rubbia‐Brandt, L., Egawa, H., Burra, P., O’Grady, J., & Watt, K. D. S. (2018) · Transplantation · doi:10.1097/tp.0000000000002485 · Cited by 92 · see citing works
Neal, D. A. J., Gimson, A. E. S., Gibbs, P., et al. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.24637 · Cited by 91 · see citing works
Liver Transplantation and Bariatric Surgery: Timing and Outcomes
Diwan, T. S., Rice, T. C., Heimbach, J. K., & Schauer, D. P. (2018) · Liver Transplantation · doi:10.1002/lt.25303 · Cited by 91 · see citing works
Strom Halden, T. A., Asberg, A., Vik, K., Hartmann, A., & Jenssen, T. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft536 · Cited by 89 · see citing works
Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment
Peláez-Jaramillo, M. J., Cárdenas-Mojica, A. A., Gaete, P. V., & Mendivil, C. O. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0374-8 · Cited by 89 · see citing works
Werzowa, J., Hecking, M., Haidinger, M., Lechner, F., Döller, D., Pacini, G., Stemer, G., Pleiner, J., Frantal, S., & Säemann, M. D. (2013) · Transplantation · doi:10.1097/tp.0b013e318276a20e · Cited by 87 · see citing works
VOGT, D. P., Henderson, J. M., Carey, W. D., et al. (2002) · Surgery · doi:10.1067/msy.2002.128343 · Cited by 82 · see citing works
Younossi, Z. M., Stepanova, M., Saab, S., Kalwaney, S., Clément, S., Henry, L. L., Frost, S., & Hunt, S. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12881 · Cited by 80 · see citing works
Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia
Almutairi, F., Peterson, T. C., Molinari, M., et al. (2009) · Liver Transplantation · doi:10.1002/lt.21710 · Cited by 77 · see citing works
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)
Lombardi, R., Onali, S., Thorburn, D., Davidson, B. R., Gurusamy, K. S., & Tsochatzis, E. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011640.pub2 · Cited by 74 · see citing works
Self-citationEvaluation of coronary artery disease in potential liver transplant recipients
Hogan, B. J., Gonsalkorala, E. S., & Heneghan, M. A. (2016) · Liver Transplantation · doi:10.1002/lt.24679 · Cited by 71 · see citing works
New‐onset diabetes after liver transplantation and its impact on complications and patient survival
Lv, C., Zhang, Y., Chen, X., Huang, X., Xue, M., Sun, Q., Wang, T., Liang, J., He, S., Gao, J., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12275 · Cited by 69 · see citing works
Barone, M., Viggiani, M. T., Losurdo, G., Principi, M., Leandro, G., & Leo, A. D. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14139 · Cited by 67 · see citing works
VanWagner, L. B., Lapin, B. R., Skaro, A. I., Lloyd‐Jones, D. M., & Rinella, M. E. (2015) · Liver International · doi:10.1111/liv.12872 · Cited by 66 · see citing works
Roccaro, G. A., Goldberg, D. S., Hwang, W., Judy, R., Thomasson, A. M., Kimmel, S. E., Forde, K. A., Lewis, J. D., & Yang, Y. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14401 · Cited by 63 · see citing works
Losurdo, G., Castellaneta, A., Rendina, M. G., Carparelli, S., Leandro, G., & Leo, A. D. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14521 · Cited by 62 · see citing works
Cassiman, D. M., Roelants, M., Vandenplas, G., der Merwe, V., Mertens, A. C., Libbrecht, L. J., Verslype, C., Fevery, J., Aerts, R., Pirenne, J., et al. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00379.x · Cited by 60 · see citing works
Metabolic and cardiovascular complications in the liver transplant recipient.
Luca, L. D., Westbrook, R., & Tsochatzis, E. A. (2015) · PubMed Central · Cited by 54 · see citing works
Self-citationKardashian, A. A., Dodge, J. L., Roberts, J. P., et al. (2017) · Liver International · doi:10.1111/liv.13523 · Cited by 54 · see citing works
Outcome of liver transplantation in patients with prior bariatric surgery
Safwan, M., Collins, K. M., Abouljoud, M. S., & Salgia, R. J. (2017) · Liver Transplantation · doi:10.1002/lt.24832 · Cited by 53 · see citing works
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients
Maira, T. D., Rubín, Á., Puchades, L., Aguilera, V., Vinaixa, C., García, M., Maria, N. D., Villa, E., López‐Andújar, R., Juan, F. S., et al. (2015) · Liver Transplantation · doi:10.1002/lt.24128 · Cited by 50 · see citing works
Vascular events after liver transplantation: a long-term follow-up study
Borg, M., van der Wouden, E. J., Sluiter, W. J., et al. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00557.x · Cited by 48 · see citing works
Wong, R. J., Cheung, R. C., Perumpail, R. B., Holt, E. W., & Ahmed, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3469-8 · Cited by 48 · see citing works
Current and future treatment options in non-alcoholic steatohepatitis (NASH)
Lazaridis, N., & Tsochatzis, E. A. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1293523 · Cited by 47 · see citing works
Self-citationGitto, S., Maria, N. D., Benedetto, F. D., et al. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001105 · Cited by 47 · see citing works
Aravinthan, A. D., Fateen, W., Doyle, A. C., Venkatachalapathy, S. V., Issachar, A., Galvin, Z., Sapisochín, G., Cattral, M. S., Ghanekar, A., McGilvray, I. D., et al. (2019) · Transplantation · doi:10.1097/tp.0000000000002757 · Cited by 46 · see citing works
Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States†
Khurmi, N. S., Chang, Y., Steidley, D. E., Singer, A. L., Hewitt, W. R., Reddy, K. S., Moss, A. A., & Mathur, A. K. (2018) · Liver Transplantation · doi:10.1002/lt.25055 · Cited by 45 · see citing works
Prospective evaluation of metabolic syndrome and its components among long‐term liver recipients
Anastácio, L. R., Diniz, K. G. D., Ribeiro, H. S., Ferreira, L. G., Lima, A. S., Correia, M. I. T. D., & Vilela, E. G. (2014) · Liver International · doi:10.1111/liv.12495 · Cited by 43 · see citing works
Wallia, A., Schmidt, K., Oakes, D. J., Pollack, T., Welsh, N., Kling-Colson, S. C., Gupta, S., Fulkerson, C., Aleppo, G., Parikh, N. D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3279 · Cited by 42 · see citing works
Carnovale, C., Pozzi, M., Dassano, A., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1257-1 · Cited by 42 · see citing works
Management of diabetes mellitus in patients undergoing liver transplantation
Grancini, V., Resi, V., Palmieri, E., Pugliese, G., & Orsi, E. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.042 · Cited by 34 · see citing works
Control of Blood Pressure in Liver Transplant Recipients
Martínez-Saldivar, B., Prieto, J. E., Berenguer, M., de la Mata, M., Pons, J. A., Serrano, T., Rafael-Valdivia, L., Aguilera, V., Barrera, P., Parrilla, P., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e31824cd5e6 · Cited by 24 · see citing works
Liu, F.-C., Lin, J., Chen, H.-P., Tsai, Y., & Yu, H. (2016) · Medicine · doi:10.1097/md.0000000000003829 · Cited by 24 · see citing works
Controlling Diabetes After Liver Transplantation
Alvarez‐Sotomayor, D., Satorres, C., Rodríguez-Medina, B., Herrero, I., de la Mata, M., Serrano, T., Rodríguez‐Perálvarez, M., D’Avola, D., Lorente, S., Rubín, Á., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001399 · Cited by 21 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008; 14(11): 1648-54.
Cited by
Sorted by citations
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210 · see citing works
- Authors
- Fatourou, E. M., & Tsochatzis, E. A.
- Affiliations
- The Royal Free Hospital (GB)
- Corresponding author
- Tsochatzis, Emmanuel A
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 4
- Issue
- 9
- Pages
- 731-741
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W2966354748
- Cited by
- 59
- References
- 88
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 4
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Locations
- The Lancet. Gastroenterology & hepatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Keywords
- metabolic syndrome, liver transplantation, cardiovascular risk, cardiovascular events, nonalcoholic steatohepatitis, metabolic comorbidities, cardiovascular disease prevention, transplant recipients
- MeSH terms
- Antihypertensive Agents, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Hypertension, Immunosuppressive Agents, Life Style, Obesity, Risk Factors, Liver Transplantation, Anti-Obesity Agents, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
